ASO Author Reflections: TP53 and PKD Co-mutations Were Associated with Poorer Prognoses in Patients with Resected EGFR-Mutated Lung Adenocarcinoma
Crossref DOI link: https://doi.org/10.1245/s10434-019-08079-z
Published Online: 2019-11-18
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Long, Hao
Liu, Di-Han
Text and Data Mining valid from 2019-11-18
Version of Record valid from 2019-11-18
Article History
Received: 30 October 2019
First Online: 18 November 2019
Disclosures
: Hao Long and Di-Han Liu have no conflicts of interest to disclose.